CCN(CC)C(=O)[C@H]1CC(CC(=O)NCCCN(C)C)C(=O)N2CCc3c([nH]c4ccccc34)[C@]12C
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?